TIDMIDH
RNS Number : 7259X
Immunodiagnostic Systems Hldgs PLC
20 August 2009
?
Immunodiagnostic Systems Holdings plc
Holding(s) in Company
Immunodiagnostic Systems Holdings plc ("IDS" or "the Company"), a leading
producer of diagnostic testing kits for the clinical and research
markets, announces that on 19 August 2009 Nordic Bioscience A/S ("Nordic")
disposed of its entire holding in IDS, with the majority of the shares being
purchased by Forum Venture Capital GmbH ("Forum"), taking their holding to
24.6%.
Following the purchase of ordinary shares Forum has a direct interest
in 6,504,364 voting shares in the Company, representing 24.6% of the issued
share capital. Prior to the transaction Forum held 4,221,064 voting shares in
IDS.
Prior to the transaction Nordic held 2,783,300 voting shares in IDS. Nordic was
the vendor of Nordic Bioscience Diagnostics A/S acquired by IDS in 2007 with the
consideration satisfied in cash and 2,783,300 IDS shares.
Enquiries:
+------------------------------------+------------------------------------+
| Immunodiagnostic Systems Holdings | Tel: 0191 519 0660 |
| Plc | |
+------------------------------------+------------------------------------+
| Roger Duggan, CEO | |
+------------------------------------+------------------------------------+
| Paul Hailes, Finance Director | |
+------------------------------------+------------------------------------+
| | |
+------------------------------------+------------------------------------+
| Brewin Dolphin Investment Banking | Tel: 0845 213 4730 |
+------------------------------------+------------------------------------+
| Andrew Emmott | |
| Sean Wyndham-Quin | |
+------------------------------------+------------------------------------+
| | |
+------------------------------------+------------------------------------+
| Walbrook PR Ltd | Tel: 020 7933 8787 |
+------------------------------------+------------------------------------+
| Paul McManus | Mob: 07980 541 893 |
+------------------------------------+------------------------------------+
| | paul.mcmanus@walbrookpr.com |
+------------------------------------+------------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUKVNRKARWAAR
|